
Global ENT Devices Market: by Product (Diagnostic Devices, Surgical Devices, Hearing Aids, Image-guided Surgery Systems, and Other Products), End User (Hospitals, ENT Clinics, and Other End Users)and byGeography (Europe, Asia-Pacific, North America, Middle East & Africa, &South America)—Global Forecast till 2032
- Description
- Additional information
Description
Market Overview: The global market for ENT devices was valued at $25.93 billion during 2023 and is anticipated to expand at a compound annual growth rate (CAGR) of 5.54% from 2024 to 2030. This growth is propelled by different factors, comprising the high incidence of ENT-related conditions, the growing adoption of minimally invasive ENT processes, and the rising elderly population. Additionally, technological advancements significantly aid the market’s expansion. The expansion of the ENT devices industry can be accredited also to different factors: the growing prevalence of sinusitis, the rapidly rising elderly population, favorable reimbursements for ENT processes in developed countries, the rising adoption of minimally invasive ENT processes, the growing presence of key players in the global market, and constant technological advancements.
Market Size for Global ENT Devices Market on the Basis of Revenues in USD Bn, 2018-2023
Source: Maven Market Research
What Factors are Leading to the Growth of the Global ENT Devices Market:
- The growth of the market is propelled by different factors, including the growing prevalence of hearing disorders, the increasing integration of technology in ENT devices, and the rising preference for minimally invasive processes within the ENT specialty.
- The requirement for advanced ENT devices, including robot-assisted endoscopes, is greater in developed countries such as the U.S. In contrast, it is lower across developing countries owing to their high cost. However, market penetration of ENT devices is projected to rise significantly due to growing healthcare expenditures by different governments and a rise in per capita income.
- Sales of ENT devices are anticipated to rise speedily in developing economies owing to the high prevalence of ENT diseases such as hearing loss and sinusitis. Furthermore, there is a growing effort to enhance access to healthcare facilities around these regions.
Which Industry Trends have been Fueling the Growth?
Growing Prevalence of ENT Devices: The global ENT devices market is witnessing significant growth, primarily owing to the growing prevalence of Ear, Nose, and Throat (ENT) disorders. Conditions including sinusitis, rhinitis, and obstructive sleep apnea are becoming more prevalent, leading to a higher requirement for effective treatment choices. Chronic sinusitis, a common ENT condition, affects a considerable portion of the population and is categorized by inflammation and swelling of the sinuses, causing symptoms including nasal congestion and facial pain. The growing incidence of these ENT disorders has resulted in an increased requirement for diagnostic and treatment solutions, thereby propelling the growth of the global ENT devices market. These devices are important for diagnosing and managing these conditions. As the incidence of ENT disorders continues to increase, there is a growing requirement for advanced diagnostic tools and treatment choices, which is projected to further propel the growth of the ENT devices market.
Rapid Population in Emerging Countries: The market is propellingowing to the globally rising aging population. Age-related issues including hearing loss and sinusitis drive the requirement for advanced diagnostic and therapeutic devices, comprising hearing aids and nasal implants. Elderly individuals considerably seek minimally invasive processes and innovative technologies to maintain their superiorityin life, further fostering market growth. Government initiatives focusedonenhancing healthcare infrastructure and raising awareness concerning ENT disorders among older adults also aid to this expansion. Additionally, producers are investing in research and development to introduce personalized solutions that meet the precise needs of elderly patients, further propelling global growth in the market.
What is the Current Structure for Global ENT Devices Market?
By Product Type, Hearing Segment Dominates the Largest Market Share
The hearing aids segment registered for the largest revenue share, exceeding 30%, during 2023 and is anticipated to rise at the fastest CAGR from 2024 to 2030. This growth is propelled by growing awareness of technologically advanced devices for hearing impairment and deafness, along with the growing prevalence of hearing loss owing to the expanding geriatric population. In addition, the segment’s growth is projected to be fostered by an increase in product launches by key players. For example, in February 2022, Oticon, Inc. announced an expansionof its hearing aid portfolio to make its improvedBrainHearing technology accessible to a wider audience with hearing loss.
By End User, Hospital Segment Held the Largest Market Share
The hospitals segment registered the global ENT devices market in terms of revenue in 2022 and is anticipated to maintain its dominance in the forecast period. The growth of this segment is fostered by the surging demand for hearing care devices and the existence of large hospital chains. The clinics segment is projected to be the fastest-rising segment in the forecast period. This growth is accredited to innovations in clinical diagnostic approaches and the growing awareness about the diagnosis and treatment of ENT diseases.
By Region, North America Holds the Largest CAGR in the Global Market
North America dominated the market with a 35% share in 2023. This dominance is accredited to different factors, comprising the high prevalence of ENT-related disorders, the existence of large hospital chains and improved ambulatory facilities, increased requirements for hearing care products, and a rapid target population. Additionally, the local existence of giant players, supportive government regulations for portable medical devices, and the high implementation of enhanced technology further propel market growth in the region.
Competitive Analysis
The ENT devices market is populated by a diversity of participants, and the projected entry of new competitors is projected to strengthen competitive pressures. Key players in the industry continually improve their technologies to maintain a competitive benefitreliant on effectiveness, reliability, and safety. These entities aimfor strategic initiatives including forming partnerships, refining their product offerings, and engaging in collaborative ventures. Their objective is to outperform competitors in the market and secure a dominating share of the ENT devices market. Some of the major players included in the market are Cochlear Ltd, Medtronic PLC, Olympus Corporation, Stryker Corporation and Sivantos Group (Signia)
Market Segmentation
Global ENT Devices Market, By Product Type
- Diagnostic ENT Devices
- Rigid Endoscopes
- Sinuscopes
- Otoscopes
- Laryngoscopes
-
- Flexible Endoscopes
- Bronchoscopes
- Laryngoscopes
- Nasopharyngoscopes
-
- Robot Assisted Endoscope
- Hearing Screening Device
- Surgical ENT Devices
- Radiofrequency handpieces
- Otological Drill Burrs
- ENT Hand Instruments
- Sinus Dilation Devices
- Nasal Packing Devices
- Hearing Aids
- Hearing Implants
- Nasal Splints
Global ENT Devices, By End Users
- Hospitals
- Ambulatory settings
- ENT clinics
- Research and academic institutes
- Others
Global ENT Devices Market, by Region
- North America
- US
- Canada
- Europe
- Germany
- UK
- Russia
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Indonesia
- Malaysia
- Rest of Asia-Pacific
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- Turkey
- South Africa
- Rest of Middle East & Africa
Market Players Included
- Ambu A/S
- Atos Medical
- Cochlear Limited
- Demant A/S
- GN Store Nord A/S
- Johnson & Johnson
- Karl Storz GmbH & Co. KG
- Medtronic
- Olympus Corporation
- Pentax of America, Inc.
- Rion Co., Ltd.
- Siemens Healthineers
- Smith & Nephew
- Sonova Holding AG
- Stryker Corporation
Additional information
Report Format | Excel, Excel + PDF/PPT |
---|
Call Or E-mail
APAC: +91 77 74 030 494
US: +91 77 74 030 494
UK: +91 77 74 030 494
info@mavenmarketreserach.com